Company news
ENDRA Life Sciences Inc. news in 2024
ENDRA Life Sciences Inc.'s news releases, calls and decks from 2024, newest first.
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
November 21, 2024
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
November 14, 2024
ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent
November 5, 2024
ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany
October 21, 2024
ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements
August 27, 2024
ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update
August 21, 2024
ENDRA Life Sciences Announces Reverse Stock Split
August 15, 2024
ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024
August 12, 2024
ENDRA Life Sciences Announces Leadership Changes
August 12, 2024
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
June 3, 2024
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
May 13, 2024
ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024
May 6, 2024
ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents
May 1, 2024
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 27, 2024
ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024
March 20, 2024
ENDRA Life Sciences Installs First TAEUS System in the UK
February 26, 2024
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe
February 13, 2024